Showing 81 - 100 of 159 results
Nuclear Medicine
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Particle Accelerators
The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.
New species of rare 100-million years old flying reptile found in Australia
An international team of academic researchers led by Curtin University have provided a description of a new species of pterosaur, a flying reptile.
Nanoprobe beamline (NANO) - under construction
The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.
International researchers overturn assumptions about the structure of most widely used hydrogel
Research confirms that methylcellulose, one of the most widely used hydrogel-forming materials in biomedical research and consumer products, organises itself into a structural architecture
Plans to safely manage medical and research waste
ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.
Sample Guide - XFM beamlime
Samples on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.
Shaun Jenkinson is currently Chief Executive Officer of ANSTO.
Nuclear NextGen – ANSTO's Work Experience Intensive Days for 2026
Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Role at ANSTO
Role at ANSTO
Role at ANSTO
Capabilities
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
ANSTO Innovation Precinct briefing for NSW Parliament
ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.
ANSTO User Meeting 2021 - Awards
You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).
Using marine fossils, a large international collaboration decodes a fundamental process in Earth's history
ANSTO has contributed to a large international study which decodes a fundamental process in Earth’s history and provides guidelines regarding the types of research questions that palaeontologists can investigate using marine fossils.